NEU FY2025 SEC EDGAR DEF 14A #106 of 168 in industry

Newmarket Corp CEO pay ratio

The CEO earned $133K in FY2025 against median worker pay of $132,938 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
VA
Filing date
2026-03-12
Industry
Chemicals & Pharmaceuticals
Industry rank
#106/168

Data updated August 2026

Subscribe to Newmarket Corp CEO pay filing updates (RSS)

CEO-to-worker pay ratio
28:1
Below Average (Scale: 0–1000:1)
CEO pay
$133K
Median worker
$132,938

Answer first

Newmarket Corp's FY2025 CEO total of $133K ranks #1363 of 1,423 complete filings; its 28:1 pay ratio ranks #1149. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $132,938. Industry placement uses the FY2025 SIC-28 peer cohort (# 106 of 168, 38th percentile - below the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#1363
$133K of 1,423 FY2025
Ratio rank
#1149
28:1 of 1,423
Industry pct
38th
below the industry median pay ratio

How Newmarket Corp ranks nationally

Newmarket Corp CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$132,938 4th percentile higher than 4% of 1,423 companies

$0–$2,500,000: 304 companies (21%). This entry sits in this band. $2,500,000–$5,000,000: 182 companies (13%). Above this entry. $5,000,000–$7,500,000: 208 companies (15%). Above this entry. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Newmarket Corp vs. Chemicals & Pharmaceuticals peers

CEO total pay ($133K) against pay ratio (28:1) for Newmarket Corp (marked) and its 3 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both03372161.56744323.010116484.613488646.127.3:131.2:135:138.9:142.7:1CEO total payPay ratio (CEO : median worker)Newmarket Corp, CEO total pay: 132938 · Pay ratio (CEO : median worker): 28:1Newmarket CorpArcutis Biotherapeutics, Inc., CEO total pay: 7223065 · Pay ratio (CEO : median worker): 28:1Arcutis Biotherapeutics, Inc.Structure Therapeutics Inc., CEO total pay: 8520403 · Pay ratio (CEO : median worker): 29:1Structure Therapeutics Inc.Protagonist Therapeutics, Inc, CEO total pay: 12852660 · Pay ratio (CEO : median worker): 30:1Protagonist Therapeutics, Inc
Newmarket Corp vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Newmarket Corp's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Newmarket Corp

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
28:1
FY2025
vs prior FY
+4:1
from FY2024 24:1
CEO $ YoY
+4%
$133K latest
Filings shown
5
FY2021–2025
Newmarket Corp CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $104K - $103,521 24:1 -
2022 $119K +15% $118,570 18:1 -6:1
2023 $105K -11% $105,392 31:1 +13:1
2024 $128K +21% $127,813 24:1 -7:1
2025 $133K +4% $132,938 28:1 +4:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1282637, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
28:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$133K
Companies in Industry
168
vs. Industry Median
Below
#106 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Newmarket Corp: MODEST · MICRO pay ratio

Newmarket Corp's FY2025 CEO total $133K ranks #1363 of 1,423 complete filings (lower third by dollars). the CEO earned 28× the median employee ($132,938) in FY2025.

Median employee $132,938 (ELITE-MED); MODEST · MICRO stamps put about 28 median-wage years per CEO year.

CEO Total Pay

$133K

FY2025 Summary Compensation, below median

Pay Ratio

28:1

Below typical

Newmarket Corp in the lower-dollar third

Newmarket Corp's FY2025 CEO total $133K ranks #1363 of 1,423 complete filings (lower third by dollars). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Newmarket Corp's $133K CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #1363 and ratio rank #1149 split - treat 28:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$133K
Median Employee Pay
$132,938
Pay Ratio
28:1
Filing Date
2026-03-12

Company Info

Ticker
NEU
CIK
1282637
Industry
Chemicals & Pharmaceuticals
SIC Code
2860
State
VA
View SEC filings →
SEC EDGAR DEF 14A for CIK 1282637, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Newmarket Corp's FY2025 CEO total $133K ranks #1363 of 1,423 complete filings (lower third by dollars).

Read with Newmarket Corp

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · MICRO · ELITE-MED.

Duke Energy CORP · MICRO

ABS(ceo_total_comp) peer at $133K (Δ $334 lighter vs Newmarket Corp); MID · ELITE-MED vs this page's MODEST · MICRO · ELITE-MED.
Schwab Charles Corp · MICRO

ABS(ceo_total_comp) peer at $131K (Δ $1K lighter vs Newmarket Corp); MID · ELITE-MED vs this page's MODEST · MICRO · ELITE-MED.
Emergent BioSolutions Inc. · MICRO

ABS(ceo_total_comp) peer at $131K (Δ $2K lighter vs Newmarket Corp); MODEST · LOW-MED vs this page's MODEST · MICRO · ELITE-MED.
Outset Medical, Inc. · MICRO

ABS(ceo_total_comp) peer at $136K (Δ $3K heavier vs Newmarket Corp); FLOOR · LOW-MED vs this page's MODEST · MICRO · ELITE-MED.
Cytokinetics Inc (SIC 28 pole)

Cytokinetics Inc stamps MODEST · UNFILED nearest in-SIC by ABS(pay_ratio) to Newmarket Corp's MODEST filing.
National dual ranks · #1363/#1149

Newmarket Corp's FY2025 package sits #1363 by CEO dollars and #1149 by ratio under MICRO · MODEST.
Ratio primer · MODEST

Newmarket Corp's MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Newmarket Corp (CIK 1282637), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.